Back to search

Article

Outcomes of Salvage Fractionated Reirradiation Combined With Bevacizumab for Recurrent High-grade Gliomas That Progressed After Treatment With Bevacizumab

2021-01-18

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: This study evaluated the outcomes of reirradiation combined with bevacizumab (Bev) for patients with recurrent high-grade gliomas that progressed after treatment with Bev.<bold>Methods</bold>: Between January 2015 and September 2019, 14 patients who experienced progression after Bev treatment were treated with reirradiation consisting of 25 Gy in five fractions...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7cda8e2-1464-5f38-ad89-51a315548078
DOI
10.21203/rs.3.rs-147697/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Outcomes of Salvage Fractionated Reirradiation Combined With Bevacizumab for Recurrent High-grade Gliomas That Progressed After Treatment With BevacizumabDOI 10.21203/rs.3.rs-147697/v1
Select a neighboring publication to make it the new centre.